California Public Employees Retirement System’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-54,400
Closed -$1.01M – 2252
2021
Q1
$1.01M Sell
54,400
-6,741
-11% -$138K ﹤0.01% 2493
2020
Q4
$1.08M Sell
61,141
-1,100
-2% -$19.3K ﹤0.01% 2421
2020
Q3
$954K Buy
62,241
+20,147
+48% +$378K ﹤0.01% 2314
2020
Q2
$1.07M Buy
42,094
+32,094
+321% +$670K ﹤0.01% 2185
2020
Q1
$155K Hold
10,000
– – ﹤0.01% 2956
2019
Q4
$111K Buy
+10,000
New +$86.9K ﹤0.01% 3266

Other funds holding KNSA

California Public Employees Retirement System's KNSA Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Kiniksa Pharmaceuticals (KNSA) in Q2 2021, closing a stake of 54,400 shares — an estimated $1.01M sold.

California Public Employees Retirement System first reported a position in KNSA in Q4 2019 and held it in 6 quarters. The position peaked at $1.08M in Q4 2020. 102 funds tracked by Wall St. Rank hold KNSA as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Kiniksa Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 54,400 Kiniksa Pharmaceuticals shares in Q2 2021, an estimated $1.01M.
  • California Public Employees Retirement System first reported a position in Kiniksa Pharmaceuticals in Q4 2019 and held it in 6 quarters.
  • California Public Employees Retirement System's Kiniksa Pharmaceuticals position peaked at $1.08M in Q4 2020.
  • 102 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.